Real-World cancer care: which drug works better after chemo?

This study looked at how well two different immunotherapy drugs work for people with advanced bladder cancer who had already received chemotherapy. Researchers followed 35 patients in real-world hospital settings to compare Avelumab (given right after chemo) and Pembrolizumab (given later if cancer returned). They tracked how long patients lived without their cancer getting worse, what side effects occurred, and the overall costs of each treatment approach.